share_log

Galectin Therapeutics | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Director ELDRED KARY

SEC ·  Jul 23, 2024 06:44
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more